Trial Profile
Randomized controlled trial of 6% cellulose sulfate gel and the effect on vaginal HIV transmission
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 15 Mar 2011
Price :
$35
*
At a glance
- Drugs Cellulose sulfate (Primary)
- Indications HIV-1 infections; HIV-2 infections
- Focus Therapeutic Use
- 31 Jul 2008 Primary endpoint results published in NEJM in July 2008
- 20 Feb 2007 Status changed from recruiting to discontinued.
- 04 Sep 2006 The expected completion date for this trial is now 1 Dec 2009.